SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.130+0.9%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BoredMember who wrote (10197)5/8/2018 1:36:49 PM
From: drkaz2 Recommendations

Recommended By
HardToFind
mattstat

  Read Replies (1) of 12873
 
If Dr. Diwan thinks that NNVC has been a successful public traded business to date - then he's an even worse businessman that I have thought he might be. He certainly appears to be a solid engineer and scientist, but business sense - that's not something borne out by results to date.

Do you believe Dr. Anil Diwan considers Nanoviricides "successful"?
You are asking absolutely the wrong question here.

In order for a public traded business to be considered successful it must have a product or service to sell, market that product, and generate profit for the owners of that public traded business.

I've been willing to cut NNVC some slack to date as by definition almost no pre-clinical stage biotech company has a product or service it can sell until after getting into and (usually) completing a clinical trial or two. That fact kind of comes with the 'pre-clinical' package.

The better measuring stick for companies in the 'pre-clinical' stage is how well they are meeting milestones so they can deliver a product or service into clinical testing. A few facts then jump out at us as regards NNVC being a success:

Many milestones missed or delayed with either bad or no explanation. Running out of working capital far more rapidly than any of us find comfortable. The front-man for the company recently unexpectedly retired, and with no new CEO waiting in the wings to take over the next stages of company development. And we have been waiting for many months now for some completed description of that last round of animal testing, leading into the last sets of hoops needed to enter into clinical testing.

NNVC has (again, to date) only been a success from the standpoint of keeping TheraCour and Dr. Diwan's private business interests funded. NNVC has not been a successful business.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News